Factor X levels, polymorphisms in the promoter region of factor X, and the risk of venous thrombosis

Thrombosis and Haemostasis

Volumn 85, Issue 6, 2001, Pages 1011-1017

  De Visser, M C H ^a   Poort, S R ^a   Vos, H L ^a   Rosendaal, F R ^a   Bertina, R M ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Factor X; Polymorphisms; Venous thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; FIBRINOGEN; ORAL CONTRACEPTIVE AGENT; PROTHROMBIN; VITAMIN K GROUP;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENOTYPE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POSTMENOPAUSE; PREDICTION; PREMENOPAUSE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN POLYMORPHISM; RISK FACTOR; VEIN THROMBOSIS;

EID: 0034976081     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615956     Document Type: Article

References (41)

1. Risk factors for venous thrombotic disease
2. Inherited antithrombin deficiency causing thrombophilia
3. Deficiency of protein C in congenital thrombotic disease
4. Familial protein S deficiency is associated with recurrent thrombosis
5. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C
6. Mutation in blood coagulation factor V associated with resistance to activated protein C
7. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
8. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men
9. A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis
10. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma protrombin levels and an increase in venous thrombosis
11. Role of clotting factor VIII in effect of Von Willebrand factor on occurrence of deep-vein thrombosis
12. High levels of factor IX increase the risk of venous thrombosis
13. High levels of coagulation factor XI as a risk factor for venous thrombosis
14. Factor II and fibrinogen levels as risk factors for venous thrombosis: A case control study of plasma levels and DNA polymorphisms - Leiden Thrombophilia Study (LETS)
15. Inherited factor X deficiency: Molecular genetics and phatophysiology
16. Blood coagulation
17. Cofactor proteins in the assembly and expression of blood clotting enzyme complexes
18. Surface-dependent reactions of the vitamin K-dependent enzyme complexes
19. Gene for human factor X: A blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C
20. Steady state levels of factor X mRNA in liver and Hep G2 cells
21. Liver-enriched transcription factor HNF-4 and ubiquitous factor NF-Y are critical for expression of blood coagulation factor X
22. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals
23. Variation in the promoter region of the beta fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers
24. Genotypic variation in the promoter region of the protein C gene is associated with plasma protein C levels and thrombotic risk
25. Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity
26. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
27. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
28. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives
29. Rabbit polyclonal antibodies against the calcium-dependent conformation of factor IX and their application in solid phase immunoradiometric assays
30. Liver-specific expression of the gene coding for human factor X, a blood coagulation factor
31. A genetic variant in the promoter of coagulation factor X increases the risk of acute coronary syndromes
32. Characterization of the human blood coagulation factor X promoter
33. On estimating the relation between blood group and disease
34. Effect of oral contraceptives on haemostasis variables
35. Molecular genetics of blood coagulation factor X
36. +14 → Lys) and its functional consequences in a hereditary factor X deficiency (factor X "Vorarlberg")
37. Friuli results from a substitution of serine for proline at position 343
38. Plasma levels of protein S, protein C, and factor X: Effects of sex, hormonal state and age
39. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: A cross-over study
40. Factor V antigen levels and venous thrombosis: Risk profile, interaction with factor V Leiden and relation with factor VII antigen levels
41. Polymorphic variation in the human protein C (PROC) gene promoter can influence transcriptional efficiency in vitro